Patent Will Also Cover a Related Method of Production of the Material Fourth U.S. Patent Directed to Use of Vidofludimus Calcium in Multiple Sclerosis Multilayered Intellectual Property Strategy Provides Protection Into 2041 in the United States and Into 2039 Internationally, Unless Extended Further NEW YORK , March 20, 2024 /PRNewswire/ -- Immunic, Inc. (Nasdaq: IMUX), a biotechnology company developing a clinical pipeline... Read More